ATXI(Delisted)
Avenue TherapeuticsยทNASDAQ
--
--(--)
ATXI Profile
Avenue Therapeutics, Inc.
A pharmaceutical company that develops an intravenous formulation of tramadol HCI for the treatment of post-operative pain
1111 Kane Concourse, Suite 301, Bay Harbor Islands, Florida 33154
--
Avenue Therapeutics, Inc., was incorporated in Delaware on February 9, 2015. The Company is a specialty pharmaceutical company focused on the development and commercialization of intravenous or IV tramadol HCl or IV tramadol for the management of moderately to moderately severe postoperative pain. The Company has an exclusive license to develop and commercialize IV tramadol in the United States and plans to seek other products developed in the acute/critical care hospital market beyond Type IV tramadol.
